---
title: "Xeloda"
slug: "xeloda"
prefix: "xeloda"
date: "2023-10-06"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Capecitabine]]

# Xeloda

- Dosing: 1,000-1,250 mg/m2 PO twice daily Ã— 2 wks every 21 d. Renal: CrCl 30-50 mL/min: 75% of dose; CrCl <30 mL/min: use contraindicated
- PK/PD: Oral prodrug of 5-FU, converted via 3-step activation process. Bioavailability âˆ¼80%, protein binding <60%, hepatic & tissue metabolism (active metabolite: 5-FU), renal excretion (96%), T1/2 0.5-1 h
- AEs: Diarrhea, hand-foot syndrome, myelosuppression, mucositis, neurologic tox, coronary vasospasm
- DDI: Inhibits CYP2C9 weakly, warfarin (BBW), oral anticoagulants (â†‘ levels of anticoagulants), phenytoin (â†‘ levels of phenytoin), leucovorin (â†‘ tox of capecitabine)
- Clinical pearls: Increased risk of fatal/sev. AEs w/ DPD deficiency. Available as 150-mg & 500-mg tablets, take w/in 30 min after a meal, radiation sensitizer, uridine triacetate used as antidote in cases of overdose, accidental ingestion, & possible DPD deficiency
